Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why do patients develop reactions to streptokinase?

M Lynch1, B L Pentecost, W A Littler

  • 1Department of Medicine, University of Queensland, Prince Charles Hospital, Chermside, Australia.

Clinical and Experimental Immunology
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and Quality-of-Life Outcomes of Omalizumab Treatment in Chronic Spontaneous Urticaria.

Irish medical journal·2026
Same author

Correction: Characteristics of infant deaths with positive hair toxicology.

Forensic science, medicine, and pathology·2026
Same author

Pharmacokinetics of Moxidectin in Bare-Nosed Wombats (Vombatus ursinus) After Intravenous, Sub-Cutaneous and Transdermal Administration.

Journal of veterinary pharmacology and therapeutics·2026
Same author

Characteristics of infant deaths with positive hair toxicology.

Forensic science, medicine, and pathology·2026
Same author

A Scoping Review Investigating the International Economic Evidence to Inform the Development of a Career Pathway for Home Support Workers.

Public health reviews·2025
Same author

An application of matching algorithms to generalize small-area estimates of chronic pain prevalence to neighbourhoods across England.

Journal of public health (Oxford, England)·2025

Minor reactions to streptokinase are not common and may not be antibody-mediated. Complement activation might play a role, but antibody levels do not predict reactions in patients receiving streptokinase therapy.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Minor reactions to streptokinase are frequent but their cause is unknown.
  • Previous assumptions linked these reactions to antibody-mediated immune responses.

Purpose of the Study:

  • To investigate the immunological basis of minor reactions to streptokinase.
  • To determine if antibody titers or complement activation predict these reactions.

Main Methods:

  • Measured specific anti-streptokinase IgG subclasses (IgG1-4) and IgE in reacting patients using ELISAs, haemagglutination, and immunoblotting.
  • Assessed complement activation via hemolytic assays and C3/C4/C3d levels.
  • Analyzed streptokinase preparations for antigenic contaminants like human albumin.

Main Results:

Related Experiment Videos

  • Patients showed low anti-streptokinase IgG and IgG1 titers; no specific IgE or other IgG subclasses were detected.
  • Anti-streptokinase IgG1 was found to fix complement, and reacting patients had low total complement levels post-reaction.
  • Antigenic albumin fragments were present in the drug but not linked to reactions.

Conclusions:

  • Low antibody titers do not predict streptokinase reactions.
  • Minor reactions to streptokinase may not be directly antibody-mediated, but complement activation could be involved.
  • Further research is needed to elucidate the exact mechanisms behind streptokinase reactions.